As of February 1st 2019, MedEye, a revolutionary medication verification tool to support nurses with medication administration to patients, will be introduced to healthcare facilities in Australia and New Zealand. MedEye has entered into an exclusive distribution agreement with med-id Pty Ltd to bring to market MedEye’s automated medication verification that will help increase medication safety in hospitals and long-term care facilities.

Dr. Paul Gooden, co-founder or med-id: “We are very excited to bring this cutting-edge artificial intelligence technology to hospitals in our region. After visiting a number of leading hospitals in Europe, where MedEye is already in use, we were convinced that MedEye would change the life of all medical professionals that administer medication to patients.”

Strong partner
Also Gauti Reynisson, CEO of MedEye is excited about the collaboration: “After introduction of MedEye in a number of European countries, we are very happy to have found a strong partner for Australia and New Zealand. The knowledge, experience and network med-id bring are of great value to us. To make sure nurses can use a sophisticated tool like MedEye to help them deliver the best care possible to their patients, we need a partner that knows healthcare and how to introduce new technology to its workers. With med-id we have found just that.”

Medication errors are never ok
Michael Beck, co-founder of med-id: “At med-id, we believe that medication errors are never okay. Patients are at the center of our mission and we now can make sure that nurses have the tool to help them be perfect at delivering the right medication at the right time and with the right dose, all the time.”